Recruiting Myelodysplastic Syndromes Studies in New Brunswick
About Myelodysplastic Syndromes Clinical Trials in New Brunswick
Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature properly. MDS can progress to acute myeloid leukemia. Treatments include growth factors, chemotherapy, and stem cell transplant.
There are currently 1 myelodysplastic syndromes clinical trials recruiting participants in New Brunswick, NJ. These studies are seeking a combined 86 participants. Research is being sponsored by Rigel Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelodysplastic Syndromes Clinical Trials in New Brunswick — FAQ
Are there myelodysplastic syndromes clinical trials in New Brunswick?
Yes, there are 1 myelodysplastic syndromes clinical trials currently recruiting in New Brunswick, NJ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Brunswick?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Brunswick research site will contact you about next steps.
Are clinical trials in New Brunswick free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Brunswick studies also compensate for your time and travel.
What myelodysplastic syndromes treatments are being tested?
The 1 active trials in New Brunswick are testing new therapies including novel drugs, biologics, and treatment approaches for myelodysplastic syndromes.
Data updated March 2, 2026 from ClinicalTrials.gov